EPSTEIN BARR VIRUS (VCA) IGM ANTIBODIES

Epstein-Barr Virus (VCA) IgM Antibodies

What it is

The Epstein-Barr Virus (VCA) IgM Antibodies test detects IgM antibodies directed against the viral capsid antigen (VCA) of EBV. Epstein-Barr Virus is a member of the herpesvirus family and the cause of infectious mononucleosis. IgM antibodies appear early in infection, typically during the acute phase, and usually decline within 4–6 weeks, making this test a useful marker for diagnosing recent or active EBV infection.

Uses

This test is used to confirm acute Epstein-Barr Virus infection, especially in patients presenting with mononucleosis-like symptoms. It is often ordered alongside EBV IgG VCA and EBNA (Epstein-Barr Nuclear Antigen) antibody tests to distinguish between acute, past, or reactivated infections. It also helps differentiate EBV from other viral or bacterial causes of prolonged fever, sore throat, or swollen lymph nodes.

Symptoms That May Lead to the Test

Doctors may recommend this test if you experience symptoms such as prolonged fever, severe sore throat, swollen lymph nodes, extreme fatigue, rash, liver enlargement, or spleen enlargement. It is particularly important for diagnosing mononucleosis in adolescents and young adults.

Abnormal Results

Positive VCA IgM: Indicates a recent or acute EBV infection, consistent with infectious mononucleosis.

Negative VCA IgM: Suggests no recent EBV infection. If symptoms persist, additional testing (EBV IgG, EBNA, or EBV DNA PCR) may be needed to check for past or chronic infection.

Risks

The test requires a standard blood sample. Risks are minimal and limited to mild pain, bruising, or dizziness at the puncture site, all of which are temporary and uncommon.